Literature DB >> 7603519

Mitochondrial DNA mutations in cardiomyopathy: combination of replacements yielding cysteine residues and tRNA mutations.

M Tanaka1, T Obayashi, M Yoneda, S A Kovalenko, S Sugiyama, T Ozawa.   

Abstract

Mutations occur in mitochondrial DNA (mtDNA) in a strand-asymmetric manner. The suppressed usage of cysteine residues in the H-strand-encoded subunits can be ascribed to the mutational instability of the codon for cysteine. The usage of cysteine was suppressed even in the L-strand-encoded ND6 subunit in which the codon for cysteine was stable. Survey of the entire sequences of mtDNA from 43 individuals revealed three amino acid replacements creating cysteine residues. A patient with fatal infantile cardiomyopathy carried a mutation causing a Tyr-->Cys replacement along with three tRNA mutations. A patient with hypertrophic cardiomyopathy carried two mutations causing a Ser-->Cys replacement and a Tyr-->Cys replacement besides two tRNA mutations. The gain of cysteine residues might accelerate the inactivation of the subunits either by reactive oxygen species or by lipid-peroxidation products, and this gain, possibly in association with tRNA mutations, can be a genetic risk factor for degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603519     DOI: 10.1002/mus.880181432

Source DB:  PubMed          Journal:  Muscle Nerve Suppl


  2 in total

1.  Pathogenesis-related mutations in the T-loops of human mitochondrial tRNAs affect 3' end processing and tRNA structure.

Authors:  Louis Levinger; Dmitri Serjanov
Journal:  RNA Biol       Date:  2012-03-01       Impact factor: 4.652

Review 2.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.